First Results from PANGAEA2.0 EVOLUTION: State of the Art Management of Patients with Secondary Progressive Multiple Sclerosis (SPMS) or at Risk for SPMS to Identify Key Parameters in Daily Clinical Practice for an Early and Unified Diagnosis

被引：0

作者：

Rauser, Benedict ^{[1
]}

Ziemssen, Tjalf ^{[2
]}

机构：

[1] Novartis Pharma GmbH, Basel, Switzerland

[2] Univ Clin Dresden, Dresden, Germany

来源：

NEUROLOGY | 2020年 / 94卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

597

引用

页数：3

共 6 条

[1] PANGAEA 2.0 EVOLUTION: state of the art multiple sclerosis patient management in daily clinical practice to identify key parameters for a more unified and early diagnosis of SPMS
Ziemssen, T.
Schulze-Topphoff, U.
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 811 - 812
[2] Characterization of patient and treatment characteristics in SPMS and at risk for SPMS patients in clinical routine: final results from the pangaea 2.0 evolution study
Baufeld, C.
Winkelmann, V.
Ziemssen, T.
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 932 - 932
[3] PANGAEA 2.0: State of the Art Multiple Sclerosis Patient Management in Daily Clinical Practice. A 3-Year Observational Study of Patients Receiving Fingolimod
Ziemssen, Tjalf
Kern, Raimar
Cornelissen, Christian
NEUROLOGY, 2016, 86
[4] PANGAEA 2.0: State of the art multiple sclerosis patient management in daily clinical practice. A 3-year observational study of patients receiving fingolimod
Ziemssen, T.
Kern, R.
Cornelissen, C.
EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 417 - 417
[5] PANGAEA 2.0: STATE OF THE ART MULTIPLE SCLEROSIS PATIENT MANAGEMENT IN DAILY CLINICAL PRACTICE. A NEW 3-YEAR OBSERVATIONAL STUDY OF PATIENTS RECEIVING FINGOLIMOD
Ziemssen, T.
Kern, R.
Cornelissen, C.
VALUE IN HEALTH, 2015, 18 (07) : A686 - A686
[6] Natalizumab versus placebo in patients with secondary progressive multiple sclerosis (SPMS): Results from ASCEND, a multicenter, double-blind, placebo-controlled, randomized phase 3 clinical trial
Steiner, Deborah
Arnold, Douglas
Freedman, Mark
Goldman, Myla
Hartung, Hans-Peter
Havrdova, Eva
Jeffery, Douglas
Kapoor, Raj
Miller, Aaron
Sellebjerg, Finn
Amarante, Diogo
Cadavid, Diego
Yu, Bei
Forrestal, Fiona
Liu, Kezhen
NEUROLOGY, 2016, 87 (02) : E22 - E22

← 1 →